Christian Lee

Cooley is advising Veritone, an artificial intelligence company, on its acquisition of Broadbean for $52 million.

Cooley advised affiliates of Fernweh Group on its definitive agreement with AZZ. Lawyers Ian Nussbaum and Bill Roegge led the Cooley team advising Fernweh.

Cooley advised restaurant chain sweetgreen on its $418.6 million initial public offering of 14,950,000 shares of Class A common stock, which now trade on the New York Stock Exchange under the symbol SG. Partners Nick Hobson, David Peinsipp, Siana Lowrey and Charlie Kim led the Cooley team advising sweetgreen.

Cooley advised the underwriters on DICE Therapeutics’ $234.6 million initial public offering of 13,800,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. BofA Securities, Inc., SVB Leerink LLC and Evercore Group L.L.C. acted as the lead book-running managers for the offering. DICE Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol “DICE,” is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Partners Charlie Kim, Christina Roupas, Kristin VanderPas and Courtney Tygesson led the Cooley team.

Cooley advised Core Scientific, a carbon-neutral vertically integrated blockchain infrastructure and mining company, on its merger agreement with special purpose acquisition company (SPAC) Power & Digital Infrastructure Acquisition Corp. The transaction values the combined company, which will be called Core Scientific Inc. and listed on the Nasdaq, at an implied pro forma fully diluted enterprise value of approximately $4.3 billion. Partners Daniel Peale, David Silverman and Nicolas Dumont led the Cooley team advising Core Scientific.